Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
PKI-166 REF: 3D-MHA72461CAS: 187724-61-4 | Min. 95% | To inquire | Mon 13 Jan 25 | |
PKI-166 REF: TM-T16549CAS: 187724-61-4 | 99.76% | 42.00 €~1,967.00 € | Tue 21 Jan 25 |
PKI-166
CAS:187724-61-4
PKI-166 is a mitochondria-targeted prodrug that has been shown to be cytotoxic in vitro and …
Formula:
C20H18N4O
Purity:
Min. 95%
Molecular weight:
330.38 g/mol
Ref: 3D-MHA72461
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
PKI-166
CAS:187724-61-4
PKI-166: oral EGF-R tyrosine kinase inhibitor (IC50: 0.7 nM), halts growth & spread of many …
Formula:
C20H18N4O
Purity:
99.76%
Color and Shape:
Solid
Molecular weight:
330.38
Ref: TM-T16549
1mg | 42.00 € | ||
5mg | 118.00 € | ||
10mg | 189.00 € | ||
25mg | 370.00 € | ||
50mg | 621.00 € | ||
100mg | 985.00 € | ||
200mg | 1,332.00 € | ||
1mL*10mM (DMSO) | 130.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025